NeuraLight Nominated for the 2025 Prix Galien USA Award in Digital Health

We are proud to share that NeuraLight has been selected as a finalist for the Prix Galien USA Award in Digital Health, one of the world’s most prestigious honors recognizing excellence in life-science innovation.

This recognition underscores our mission to advance precision neurology through AI-powered biomarkers that quantify brain function via eye-movement. By translating decades of neuroscience into a practical, scalable tool, NeuraLight delivers new levels of sensitivity and objectivity in neurological assessment.

We are honored to stand alongside fellow innovators shaping the future of digital health and advancing neurology through validated, data-driven science. As we continue our journey to make neurological assessment more data-driven, accessible, and actionable, we extend our gratitude to our partners, collaborators, and the clinical community for their trust and support.

About the Prix Galien

The Prix Galien Awards, presented by the Galien Foundation, celebrate the most impactful achievements in improving human health. Widely regarded as the “Nobel Prize of life sciences” the awards recognize excellence in innovation across biotechnology, pharmaceuticals, and digital health. Learn more about our nomination at https://tinyurl.com/yc74vv26